COVID-19 vaccine effectiveness
(Randomized evidence)
Search studies
| Trial | Type | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Intervention 1 | Intervention 2 | |||||||
|
NCT04530396 Gamaleya Research Institute (Sputnik V) Logunov D, Lancet, 2021 RESIST Full text Commentary ; Commentary ; Commentary |
Non replicating viral vector |
Gam-COVID-Vac rAd26-S |
Placebo D0/21 |
RCTPhase 3 | SARS-CoV-2- and HIV infection-free adult volunteers at 25 centers in Russia | N= 21977 |
Some concerns Details |
|